NEW YORK, Dec. 17, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”   jwplayer(‘myplayer1’).setup({file: ‘https://mma.prnasia.com/media2/2847761/NYSE_Market_Update_Dec_17.mp4’, image: ‘https://mma.prnasia.com/media2/2847761/NYSE_Market_Update_Dec_17.mp4?p=thumbnail’, autostart:’false’, stretching : ‘uniform’, width: ‘512’, height: ‘288’});

Kristen Scholer delivers the pre-market update on December 17th

U.S. equities are modestly higher as Wall Street digests delayed economic reports from the government shutdown. Non-farm payrolls showed a cooling labor market, but not enough to spark expectations of a rate cut before the Fed’s Jan. 28 decision. Tax advisory firm Andersen rings the opening bell after raising $176M at $16/share (NYSE: ANDG). Watch NYSE Live at 9 a.m. ET on the NYSE TV app for CEO Mark Vorsatz’s remarks and an exclusive trading floor interview. The TOV ETF team rings the closing bell ahead of a Menorah lighting ceremony. TOV invests through a "Jewish lens" and has ties to the ADL. Catch Taking Stock at 4 p.m. ET on LinkedIn featuring ADL CEO Jonathan Greenblatt.

Opening BellAndersen Group (NYSE: ANDG) celebrates its IPO

Closing BellThe ADL and JLens Network celebrate the first Jewish advocacy ETF, TOV

Click here to download the NYSE TV App

 

 

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

IFS delivers exceptional FY2025 growth as Industrial AI scales from first deployment to commercial impact

Market-leading ARR growth, margin expansion and net retention underscore accelerating adoption of purpose-built…

SAJ Electric Honoured with EUPD Top Innovation Award at All-Energy

The EK70 HS5 Series and EK90 HS5 Series were recognised in the…

Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS

NANTONG, China, Aug. 6, 2026 /PRNewswire/ — Ractigen Therapeutics, a clinical-stage biotechnology company…